Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Erbitux cetuximab regulatory update

MRK submitted an application to EMEA to expand the label

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE